Related Content
- Walgreens puts its money where its mouth is with World AIDS Day campaign
- FDA approves Merck's Gardasil for prevention of anal cancer
- Walgreens launches high-impact push in support of World AIDS Day campaign
- Walgreens allies with HHS to launch free flu shot outreach to disadvantaged
- PhRMA: Nearly 300 preventive medicines for heart disease, stroke in development
HAWTHORNE, N.Y. — The Food and Drug Administration has approved a topical treatment for skin conditions made by Israeli generic drug maker Taro Pharmaceutical Industries.
Taro announced Monday the approval of imiquimod cream in the 5% strength. The drug is used to treat actinic keratosis and external genital warts, and is a generic version of Graceway Pharmaceuticals’ Aldara.
Imiquimod cream has annual sales of around $340 million in the United States, according to Taro.
